Author:
Lai Paul B. S.,Chi Tian-Yi,Chen George G.
Publisher
Springer Science and Business Media LLC
Subject
Cancer Research,Biochemistry (medical),Cell Biology,Clinical Biochemistry,Pharmaceutical Science,Pharmacology
Reference25 articles.
1. Hollstein M, Sidransky D, Vogelstein B, Harris CC (1991) p53 mutations in human cancers. Science 253:49–53
2. Takahashi T, Carbone D, Takashi T, Nau MM, Hida T, Linnoila Z, Ueda RR, Minna J D (1992) Wild-type but mutant p53 suppresses the growth of human lung cancer cells bearing multiple genetic lesions. Cancer Res 52:2340–2343
3. Dameron KM, Volpert OV, Tainsky MA, Bouck N (1994) Control of angiogenesis in fibroblasts by p53 regulation of angiogenesis of thrombospondin-1. Science 265:1582–1584
4. El-Deiry WS, Tokino T, Velculesu VE, Levy DB, Parsons R, Trent J, Lin D, Mercer WE, Kinzler KW, Vogelstein B (1993) WAF1, a potential mediator of p53 tumour suppression. Cell 75:817–825
5. Harper JW, Adami GR, Wei N, Keyomarsi K, Elledge SJ (1993) The p21 Cdk-interacting Cip1 is a potent inhibitor of G1 cyclin-dependent kinase. Cell 75:805–816
Cited by
65 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献